Are routine fluids administered over the course of chemotherapy to maintain line patency prior to drugs separately reportable as hydration therapy?
Routine fluids administered during the course of chemotherapy to maintain line patency (KVO or TKO) prior to or between drugs or anti-neoplastics are not separately reported as hydration therapy.
This question was answered in our Coding Essentials for Infusion & Injection Therapy Services. For more hot topics relating to infusion services, please visit our store or call us at 1.800.252.1578, ext. 2.